IP Library Granted Patent US 11,278,511
Granted Patent B2
US 11,278,511 · App. 16/906,850 · Granted Mar 22, 2022

Sports health performance composition

Inventors: Beth Anne-Szkudlarek Brown (Plymouth, MN); Anthony Lemus (Villa Park, CA); Marnie L. Peterson (Jackson, WY)
Assignee: REV PHARMACEUTICALS, INC.
A61K31/198A61K9/0014A61K9/107A61K31/352A61K45/06A61K47/183A61N1/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,511
App. No.
16/906,850
Granted
Mar 22, 2022
Kind
B2
Abstract

A topical composition that includes L-arginine that is used as a sports health composition. The composition can further include forskolin. Disclosed is a method of using the topical composition.

Claims (9)

1. A method for dilating blood vessels and thereby allowing lactic acid to dissipate from muscular tissue during exercise or during the recovery phase after exercise comprising delivering a topical composition to an area of the skin where desired, wherein the topical composition comprises about 20-40 wt % L-arginine, about 0.01-1 wt % forskolin, about 10-35 wt % skin penetration enhancer consisting of a mixture of methyl salicylate and menthol, and about 40-70 wt % base or carrier component.

2. The method of claim 1 , wherein the L-arginine is L-arginine ethyl ester, L-arginine hydrochloride or a free base of L-arginine.

3. The method of claim 1 , wherein the base is selected from oil in water emulsion, water in oil emulsion, anhydrous silicone base, lipophilic foam base, transdermal cream base, or transdermal gel base.

4. The method of claim 1 , wherein methyl salicylate is in a range of about 10 wt % to 20 wt % based on the total weight of the topical composition.

5. The method of claim 1 , wherein the topical composition is in a form of a gel, cream, ointment, foam, spray or patch.

6. The method of claim 1 , wherein the topical composition further comprises a pain reliever or a muscle relaxant.

7. The method of claim 1 , wherein the 10-35 wt % skin penetration enhancer consisting of a mixture of methyl salicylate and menthol consists of about 1-16 wt % of the menthol with the remainder consisting of the methyl salicylate.

8. The method of claim 1 , wherein the topical composition further comprises an active component selected from the group consisting of NSAIDS, COX-2 inhibitors, narcotic pain medication, central analgesics, narcotic analgesics, aspirin, topical analgesics, topical anesthetics, and a combination thereof.

9. The method of claim 1 , further comprising delivering the topical composition in combination with electrostimulation.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2022
From: BROWN, BETH ANNE-SZKUDLAREK; LEMUS, ANTHONY; PETERSON, MARNIE L.
To: REV PHARMACEUTICALS, LLC.
Reel/Frame 058715/0871 →
CHANGE OF NAME Recorded Jan 18, 2022
From: ORENDA BIOSCIENCES, LLC
To: REV PHARMACEUTICALS, INC.
Reel/Frame 058767/0404 →
CHANGE OF NAME Recorded Jan 11, 2022
From: REV PHARMACEUTICALS, LLC
To: ORENDA BIOSCIENCES, LLC
Reel/Frame 058700/0528 →
Continuity (3)
Division 15474375 · Mar 30, 2017
Provisional Application 62315859 · Mar 31, 2016
Related Publication 20200316004A1 · Oct 8, 2020